Literature DB >> 3817579

Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects.

C A Edwards, S Holden, C Brown, N W Read.   

Abstract

The effect of cisapride, a new gastrointestinal prokinetic agent, on the transit of a standard meal through the stomach, small intestine and colon was studied in 10 normal subjects. Cisapride had no significant effect on gastric emptying but decreased mouth to caecum transit time (p less than 0.01). Stool weight and frequency were not significantly increased but the time for the first appearance of stool markers and the arrival of 20% and 50% of stool markers was decreased after cisapride (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817579      PMCID: PMC1432737          DOI: 10.1136/gut.28.1.13

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.

Authors:  P A Cann; N W Read; C D Holdsworth
Journal:  Gut       Date:  1983-12       Impact factor: 23.059

2.  Second European symposium on gastrointestinal motility. Oxford, 5-7 September 1984. Abstracts.

Authors: 
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

3.  Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose.

Authors:  A M Holgate; N W Read
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

4.  Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea.

Authors:  N W Read; C A Miles; D Fisher; A M Holgate; N D Kime; M A Mitchell; A M Reeve; T B Roche; M Walker
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

Review 5.  Intraluminal pressures during perfusion of the human colon in situ.

Authors:  A Chauve; G Devroede; E Bastin
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

6.  Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).

Authors:  R Jian; F Ducrot; C Piedeloup; J Y Mary; Y Najean; J J Bernier
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

  6 in total
  26 in total

Review 1.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  Effect of cisapride on chronic idiopathic constipation in children.

Authors:  A Staiano; S Cucchiara; M R Andreotti; R Minella; G Manzi
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 3.  Orocaecal transit time in health and disease.

Authors:  I T Gilmore
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

4.  Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study.

Authors:  T Takeda; H Konomi; G Naritomi; J Yoshida; H Matsunaga; K Akazawa; M Tanaka
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 5.  Subclinical colonic thickening.

Authors:  P J Oades; M Rosenthal; E J Mac Sweeney; A Bush
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

6.  Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects.

Authors:  L M Akkermans; A Vos; A Hoekstra; J M Roelofs; M Horowitz
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

7.  Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.

Authors:  E P Bouras; M Camilleri; D D Burton; S McKinzie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

8.  A comparison of stool characteristics from normal and constipated people.

Authors:  B W Aichbichler; H H Wenzl; C A Santa Ana; J L Porter; L R Schiller; J S Fordtran
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 9.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

10.  Cisapride in neurologically impaired children with chronic constipation.

Authors:  A Staiano; E Del Giudice; D Simeone; E Miele; A Marino
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.